CT

Capstan Therapeutics at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

Capstan Therapeutics brings 2 presentations to PEGS Europe 2026 in Lisbon. Its contribution looks at engineering the immune system inside the body, with mRNA carried to T cells in targeted lipid particles so CAR-T therapy is made in place.

OrganizationPEGS Europe 2026 Attendance
CT
Capstan Therapeutics
San Diego, CA
Biotech
Develops in vivo CAR-T therapies that deliver mRNA to T cells with targeted lipid nanoparticles; acquired by AbbVie in 2025.
Talk
Wed Nov 18
8:30am–9:00am
Toward in vivo Engineering of the Immune System
Advances in Immunoengineering
Chair
Wed Nov 18
2:00pm–2:05pm
Chairperson's Remarks
Advances in Immunoengineering

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Capstan Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction